开发一种转基因乳糖菌株,产生单链可变片段,准介素-6受体α,抑制血清粉样蛋白A

Masahiro Yoda1, Kaho Suzuki2, Shoko Yoda3

  • 1Graduate School of Medicine, Science and Technology, Shinshu University, Nagano, 399-4598, Japan.

Current microbiology
|September 26, 2025
PubMed
概括

一种新型的基因工程乳糖菌株Lactococcus lactis产生一种低成本的治疗性蛋白质,向Interleukin-6受体α (IL-6Rα),为炎症疾病治疗提供了潜在的替代方案.